Personalized mechanical ventilation guided by ultrasound in patients with acute respiratory distress syndrome (PEGASUS): study protocol for an international randomized clinical trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
07 May 2024
Historique:
received: 22 12 2023
accepted: 26 04 2024
medline: 8 5 2024
pubmed: 8 5 2024
entrez: 7 5 2024
Statut: epublish

Résumé

Acute respiratory distress syndrome (ARDS) is a frequent cause of hypoxemic respiratory failure with a mortality rate of approximately 30%. Identifying ARDS subphenotypes based on "focal" or "non-focal" lung morphology has the potential to better target mechanical ventilation strategies of individual patients. However, classifying morphology through chest radiography or computed tomography is either inaccurate or impractical. Lung ultrasound (LUS) is a non-invasive bedside tool that can accurately distinguish "focal" from "non-focal" lung morphology. We hypothesize that LUS-guided personalized mechanical ventilation in ARDS patients leads to a reduction in 90-day mortality compared to conventional mechanical ventilation. The Personalized Mechanical Ventilation Guided by UltraSound in Patients with Acute Respiratory Distress Syndrome (PEGASUS) study is an investigator-initiated, international, randomized clinical trial (RCT) that plans to enroll 538 invasively ventilated adult intensive care unit (ICU) patients with moderate to severe ARDS. Eligible patients will receive a LUS exam to classify lung morphology as "focal" or "non-focal". Thereafter, patients will be randomized within 12 h after ARDS diagnosis to receive standard care or personalized ventilation where the ventilation strategy is adjusted to the morphology subphenotype, i.e., higher positive end-expiratory pressure (PEEP) and recruitment maneuvers for "non-focal" ARDS and lower PEEP and prone positioning for "focal" ARDS. The primary endpoint is all-cause mortality at day 90. Secondary outcomes are mortality at day 28, ventilator-free days at day 28, ICU length of stay, ICU mortality, hospital length of stay, hospital mortality, and number of complications (ventilator-associated pneumonia, pneumothorax, and need for rescue therapy). After a pilot phase of 80 patients, the correct interpretation of LUS images and correct application of the intervention within the safe limits of mechanical ventilation will be evaluated. PEGASUS is the first RCT that compares LUS-guided personalized mechanical ventilation with conventional ventilation in invasively ventilated patients with moderate and severe ARDS. If this study demonstrates that personalized ventilation guided by LUS can improve the outcomes of ARDS patients, it has the potential to shift the existing one-size-fits-all ventilation strategy towards a more individualized approach. The PEGASUS trial was registered before the inclusion of the first patient, https://clinicaltrials.gov/ (ID: NCT05492344).

Sections du résumé

BACKGROUND BACKGROUND
Acute respiratory distress syndrome (ARDS) is a frequent cause of hypoxemic respiratory failure with a mortality rate of approximately 30%. Identifying ARDS subphenotypes based on "focal" or "non-focal" lung morphology has the potential to better target mechanical ventilation strategies of individual patients. However, classifying morphology through chest radiography or computed tomography is either inaccurate or impractical. Lung ultrasound (LUS) is a non-invasive bedside tool that can accurately distinguish "focal" from "non-focal" lung morphology. We hypothesize that LUS-guided personalized mechanical ventilation in ARDS patients leads to a reduction in 90-day mortality compared to conventional mechanical ventilation.
METHODS METHODS
The Personalized Mechanical Ventilation Guided by UltraSound in Patients with Acute Respiratory Distress Syndrome (PEGASUS) study is an investigator-initiated, international, randomized clinical trial (RCT) that plans to enroll 538 invasively ventilated adult intensive care unit (ICU) patients with moderate to severe ARDS. Eligible patients will receive a LUS exam to classify lung morphology as "focal" or "non-focal". Thereafter, patients will be randomized within 12 h after ARDS diagnosis to receive standard care or personalized ventilation where the ventilation strategy is adjusted to the morphology subphenotype, i.e., higher positive end-expiratory pressure (PEEP) and recruitment maneuvers for "non-focal" ARDS and lower PEEP and prone positioning for "focal" ARDS. The primary endpoint is all-cause mortality at day 90. Secondary outcomes are mortality at day 28, ventilator-free days at day 28, ICU length of stay, ICU mortality, hospital length of stay, hospital mortality, and number of complications (ventilator-associated pneumonia, pneumothorax, and need for rescue therapy). After a pilot phase of 80 patients, the correct interpretation of LUS images and correct application of the intervention within the safe limits of mechanical ventilation will be evaluated.
DISCUSSION CONCLUSIONS
PEGASUS is the first RCT that compares LUS-guided personalized mechanical ventilation with conventional ventilation in invasively ventilated patients with moderate and severe ARDS. If this study demonstrates that personalized ventilation guided by LUS can improve the outcomes of ARDS patients, it has the potential to shift the existing one-size-fits-all ventilation strategy towards a more individualized approach.
TRIAL REGISTRATION BACKGROUND
The PEGASUS trial was registered before the inclusion of the first patient, https://clinicaltrials.gov/ (ID: NCT05492344).

Identifiants

pubmed: 38715118
doi: 10.1186/s13063-024-08140-7
pii: 10.1186/s13063-024-08140-7
doi:

Banques de données

ClinicalTrials.gov
['NCT05492344']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

308

Investigateurs

A K M Arif Uddin Ahmed (AKMAU)
Mohammad Jhahidul Alam (MJ)
Mohsammad Rafiqual Alam (MR)
Anjan Bal (A)
Samarjit Barua (S)
Rajdeep Biswas (R)
Mohammed Abdur Rahaman Chowdhury (MAR)
Safiqul Mostafa Chy (SM)
Satyajit Dhar (S)
Pranay Kumar Dutta (PK)
Syeda Nafisa Khatoon (SN)
Ranjan Kumar Nath (RK)
Nahid Nowroz (N)
Mithun Shil (M)
Rachid Attou (R)
Leonel Barreto Gutierrez (LB)
Keitiane Kaefer (K)
Morten Bestle (M)
Lars Hein (L)
Thomas Hildebrandt (T)
Jacob Jensen (J)
Sanne Lauritzen (S)
Ulf Pedersen (U)
Lone Poulsen (L)
Harry Giannopoulos (H)
Katerina Vaporidi (K)
Lauren Ferguson (L)
Yvelynne Kelly (Y)
Sabina Mason (S)
Aisling McMahon (A)
Bairbre McNicholas (B)
Daniele Biasucci (D)
Gianmaria Cammarota (G)
Maurizio Follino (M)
Salvatore Grasso (S)
Antonio Latela (A)
Giovanna Magnesa (G)
Fabrizia Massaro (F)
Leonarda Maurmo (L)
Marco Pezzuto (M)
Savino Spadaro (S)
Luigi Vetrugno (L)
Massimo Zambon (M)
Daan Filippini (D)
Peter Klompmaker (P)
Amne Mousa (A)
Dominik Daszuta (D)
Miłosz Jankowski (M)
Irene Aragao (I)
Heloisa Castro (H)
Vasco Costa (V)
Cristina Torrão (C)
Toni Antoni (T)
Marta Arroyo (M)
Marta Briva (M)
Nuria Duran (N)
Marina García-de-Acilu (M)
Gemma Goma (G)
Ana Ochagavia (A)
Michelle Chew (M)
Mariangela Pellegrini (M)
Gaetano Perchiazzi (G)

Informations de copyright

© 2024. The Author(s).

Références

Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, et al. Acute respiratory distress syndrome. Nat Rev Dis Prim. 2018;5(1). Available from: https://doi.org/10.1038/s41572-019-0069-0 .
Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA - J Am Med Assoc. 2016;315(8):788–800.
doi: 10.1001/jama.2016.0291
Chiumello D, Coppola S, Froio S, Gotti M. What’s next after ARDS: Long-term outcomes. Respir Care. 2016;61(5):689–99.
doi: 10.4187/respcare.04644 pubmed: 27121623
Matthay MA, McAuley DF, Ware LB. Clinical trials in acute respiratory distress syndrome: challenges and opportunities. Lancet Respir Med. 2017;5(6):524–34.
doi: 10.1016/S2213-2600(17)30188-1 pubmed: 28664851
Bos LDJ, Artigas A, Constantin JM, Hagens LA, Heijnen N, Laffey JG, et al. Precision medicine in acute respiratory distress syndrome: Workshop report and recommendations for future research. Eur Respir Rev. 2021;30(159):1–11.
doi: 10.1183/16000617.0317-2020
Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: The Berlin definition. JAMA - J Am Med Assoc. 2012;307(23):2526–33.
Constantin JM, Grasso S, Chanques G, Aufort S, Futier E, Sebbane M, et al. Lung morphology predicts response to recruitment maneuver in patients with acute respiratory distress syndrome. Crit Care Med. 2010;38(4):1108–17.
doi: 10.1097/CCM.0b013e3181d451ec pubmed: 20154600
Constantin JM, Jabaudon M, Lefrant JY, Jaber S, Quenot JP, Langeron O, et al. Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single-blind, randomised controlled trial. Lancet Respir Med. 2019;7(10):870–80.
doi: 10.1016/S2213-2600(19)30138-9 pubmed: 31399381
Smit MR, Hagens LA, Heijnen NFL, Pisani L, Cherpanath TGV, Dongelmans DA, de Grooth HS, Pierrakos C, Tuinman PR, Zimatore C, Paulus F, Schnabel RM, Schultz MJ, Bergmans DCJJ, Bos LDJ; DARTS Consortium members. Lung Ultrasound Prediction Model for Acute Respiratory Distress Syndrome: A Multicenter Prospective Observational Study. Am J Respir Crit Care Med. 2023;207(12):1591–601. https://doi.org/10.1164/rccm.202210-1882OC .
Riviello ED, Kiviri W, Twagirumugabe T, Mueller A, Banner-Goodspeed VM, Officer L, et al. Hospital incidence and outcomes of the acute respiratory distress syndrome using the Kigali modification of the Berlin definition. Am J Respir Crit Care Med. 2016;193(1):52–9.
doi: 10.1164/rccm.201503-0584OC pubmed: 26352116
Mojoli F, Bouhemad B, Mongodi S, Lichtenstein D. Lung ultrasound for critically ill patients. Am J Respir Crit Care Med. 2019;199(6):701–14.
doi: 10.1164/rccm.201802-0236CI pubmed: 30372119
Chiumello D, Mongodi S, Algieri I, LucaVergani G, Orlando A, Via G, et al. Assessment of lung aeration and recruitment by CT scan and ultrasound in acute respiratory distress syndrome patients. Crit Care Med. 2018;46(11):1761–8.
doi: 10.1097/CCM.0000000000003340 pubmed: 30048331
See KC, Ong V, Wong SH, Leanda R, Santos J, Taculod J, et al. Lung ultrasound training: curriculum implementation and learning trajectory among respiratory therapists. Intensive Care Med. 2016;42(1):63–71.
doi: 10.1007/s00134-015-4102-9 pubmed: 26474994
Smit MR, de Vos J, Pisani L, Hagens LA, Almondo C, Heijnen NFL, et al. Comparison of Linear and Sector Array Probe for Handheld Lung Ultrasound in Invasively Ventilated ICU Patients. Ultrasound Med Biol. 2020;46(12):3249–56.
doi: 10.1016/j.ultrasmedbio.2020.08.016 pubmed: 32962892
Vercesi V, Pisani L, van Tongeren PSI, Lagrand WK, Leopold SJ, Huson MMA, et al. External confirmation and exploration of the Kigali modification for diagnosing moderate or severe ARDS. Intensive Care Med. 2018;44(4):523–4. Available from: https://doi.org/10.1007/s00134-018-5048-5 .
doi: 10.1007/s00134-018-5048-5 pubmed: 29368056
Pierrakos C, Smit MR, Pisani L, Paulus F, Schultz MJ, Constantin J-M, et al. Lung Ultrasound Assessment of Focal and Non-focal Lung Morphology in Patients With Acute Respiratory Distress Syndrome. Front Physiol. 2021;12(September):1–10.
Weiss CH, McSparron JI, Chatterjee RS, Herman D, Fan E, Wilson KC, et al. Summary for clinicians: Mechanical ventilation in adult patients with acute respiratory distress syndrome clinical practice guideline. Ann Am Thorac Soc. 2017;14(8):1235–8.
doi: 10.1513/AnnalsATS.201704-332CME pubmed: 28763269 pmcid: 5566274
Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351(4):327–36. https://doi.org/10.1056/NEJMoa032193 .
Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT WA. Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome. Surv Anesthesiol. 2001;45(1):19–20.
doi: 10.1097/00132586-200102000-00017
Young D, Harrison DA, Cuthbertson BH, Rowan K. Effect of Early vs Late Tracheostomy. Jama. 2013;309(20):2121–9.
doi: 10.1001/jama.2013.5154 pubmed: 23695482
Ely EW, Truman B, Shintani A, Thomason JW, Wheeler AP, Gordon S, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003;289(22):2983–91. https://doi.org/10.1001/jama.289.22.2983 .
Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O’Neal PV, Keane KA, et al. The Richmond Agitation-Sedation Scale: Validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338–44.
Krutsinger DC, Yadav KN, Harhay MO, Bartels K, Courtright KR. A systematic review and meta-analysis of enrollment into ARDS and sepsis trials published between 2009 and 2019 in major journals. Crit Care. 2021;25(1):1–8.
doi: 10.1186/s13054-021-03804-1
European Medicines Agency | Biostatistics. https://www.ema.europa.eu/en/human-regulatory-overview/research-and-development/scientific-guidelines/clinical-efficacy-safety-guidelines/biostatistics . Accessed 6 May 2024.
Chen H, Sun Q, Chao Y, Liu Y, Yu Q, Xie J, et al. Lung morphology impacts the association between ventilatory variables and mortality in patients with acute respiratory distress syndrome. Crit Care. 2023;27(1):1–10.
doi: 10.1186/s13054-023-04350-8
Rubenfeld GD, Caldwell E, Granton J, Hudson LD, Matthay MA. Interobserver variability in applying a radiographic definition for ARDS. Chest. 1999;116(5):1347–53. Available from: https://doi.org/10.1378/chest.116.5.1347 .
doi: 10.1378/chest.116.5.1347 pubmed: 10559098
Grasselli G, Calfee CS, Camporota L, Poole D, Amato MBP, Antonelli M, et al. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Berlin Heidelberg: Intensive Care Medicine. Springer; 2023.

Auteurs

Jante S Sinnige (JS)

Department of Intensive Care, Amsterdam University Medical Centres (UMC), University of Amsterdam, Meibergdreef 9, Amsterdam, AZ, 1105, The Netherlands. j.s.sinnige@amsterdamumc.nl.

Marry R Smit (MR)

Department of Intensive Care, Amsterdam University Medical Centres (UMC), University of Amsterdam, Meibergdreef 9, Amsterdam, AZ, 1105, The Netherlands.

Aniruddha Ghose (A)

Department of Medicine, Chattogram Medical Centre, Chattogram, Bangladesh.

Harm-Jan de Grooth (HJ)

Department of Intensive Care, UMC, Vrije Universiteit, Amsterdam, HV, 1081, The Netherlands.

Theis Skovsgaard Itenov (TS)

Department of Anesthesiology and Intensive Care, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Eleni Ischaki (E)

First Department of Intensive Care Medicine, University of Athens Medical School, 10676, Athens, AZ, Greece.

John Laffey (J)

Anaesthesia and Intensive Care Medicine, School of Medicine, Galway University Hospitals, University of Galway, Galway, H91 TK33, Ireland.

Frederique Paulus (F)

Department of Intensive Care, Amsterdam University Medical Centres (UMC), University of Amsterdam, Meibergdreef 9, Amsterdam, AZ, 1105, The Netherlands.

Pedro Póvoa (P)

NOVA Medical School, CHRC, NOVA University of Lisbon, Lisbon, Portugal.
Center for Clinical Epidemiology and Research Unit of Clinical Epidemiology, OUH Odense University Hospital, Odense, Denmark.
Department of Intensive Care, Hospital de São Francisco Xavier, CHLO, Lisbon, Portugal.

Charalampos Pierrakos (C)

Department of Intensive Care, Amsterdam University Medical Centres (UMC), University of Amsterdam, Meibergdreef 9, Amsterdam, AZ, 1105, The Netherlands.
Department of Intensive Care, Brugmann University Hospital, Université Libre de Bruxelles, 1050, Brussels, Belgium.

Luigi Pisani (L)

Department of Intensive Care, Amsterdam University Medical Centres (UMC), University of Amsterdam, Meibergdreef 9, Amsterdam, AZ, 1105, The Netherlands.
Department of Precision-Regenerative Medicine and Jonic Area (DiMePRe-J), Section of Anesthesiology and Intensive Care Medicine, University of Bari Aldo Moro, Bari, Italy.

Oriol Roca (O)

Servei de Medicina Intensiva, Parc Taulí Hospital Universitari, Institut de Recerca Part Taulí (I3PT-CERCA), Parc del Taulí 1, 08028, Sabadell, Spain.
Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Marcus J Schultz (MJ)

Department of Intensive Care, Amsterdam University Medical Centres (UMC), University of Amsterdam, Meibergdreef 9, Amsterdam, AZ, 1105, The Netherlands.
Mahidol Oxford Tropical Medicine Research Unit (MORU), Mahidol University, Bangkok, 10400, Thailand.
Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7BN, UK.

Konstanty Szuldrzynski (K)

Department of Anaesthesiology and Intensive Care, National Institute of Medicine of the Ministry of Interior and Administration, 02-507, Warsaw, Poland.

Pieter R Tuinman (PR)

Department of Intensive Care, UMC, Vrije Universiteit, Amsterdam, HV, 1081, The Netherlands.
Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, Netherlands.

Claudio Zimatore (C)

Department of Intensive Care, Amsterdam University Medical Centres (UMC), University of Amsterdam, Meibergdreef 9, Amsterdam, AZ, 1105, The Netherlands.
Department of Emergency and Organ Transplantation, University of Bari Aldo Moro, 70124, Bari, Italy.

Lieuwe D J Bos (LDJ)

Department of Intensive Care, Amsterdam University Medical Centres (UMC), University of Amsterdam, Meibergdreef 9, Amsterdam, AZ, 1105, The Netherlands.
Department of Pulmonology, Amsterdam UMC, University of Amsterdam, Amsterdam, AZ, 1105, The Netherlands.
Laboratory of Experimental Intensive Care and Anaesthesiology (L.E.I.C.A.), University of Amsterdam, Amsterdam, AZ, 1105, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH